Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen for Acclimatization to High Altitude
NCT02233582Phase 1Completed
- Sponsor
- University of California, San Francisco
- Start
- Sep 2014
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in acute mountain sickness (AMS) comparing Ibuprofen with Placebo (2 arms). Primary endpoints: Blood cytokine levels at Day 4 and Cerebral blood flow at Day 4. Started Sep 2014; status: completed.
02
Drugs
ibuprofen
03
Conditions
acute mountain sickness (AMS)
Beyond the preview
Go deeper on NCT02233582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02233582.